<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2794-1140</journal-id>
<journal-title><![CDATA[Pharmaceutical Care España]]></journal-title>
<abbrev-journal-title><![CDATA[Pharm Care Esp.]]></abbrev-journal-title>
<issn>2794-1140</issn>
<publisher>
<publisher-name><![CDATA[Fundación Pharmaceutical Care España]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2794-11402025000100604</article-id>
<article-id pub-id-type="doi">10.60103/phc.v27.e874</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación de la efectividad de los Sistemas Personalizados de Dosificación (SPD) en la incidencia de PRM/RNM y problemas de salud en una farmacia comunitaria. Estudio de cohortes retrospectivo]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of the effectiveness of Personalized Dosing System in the incidence of DRP/NMR and health problems in a community pharmacy. Retrospective cohort study]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valles Martín]]></surname>
<given-names><![CDATA[Elena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barranco López]]></surname>
<given-names><![CDATA[Davinia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez-Serranía]]></surname>
<given-names><![CDATA[María-Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Treceño Lobato]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Europea Miguel de Cervantes (UEMC) Facultad de Ciencias de la Salud Grupo de Investigación Estratégico ADViSE]]></institution>
<addr-line><![CDATA[Valladolid ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Aula de Atención Farmacéutica de la Universidad de Salamanca (AUSAF)  ]]></institution>
<addr-line><![CDATA[Salamanca ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Farmacia Caparrós y Reina  ]]></institution>
<addr-line><![CDATA[Santa María del Águila Almería]]></addr-line>
<country>España</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Vicepresidente de la Fundación Pharmaceutical Care España  ]]></institution>
<addr-line><![CDATA[Barcelona ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>27</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2794-11402025000100604&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2794-11402025000100604&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2794-11402025000100604&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Introducción: La no adherencia a los tratamientos farmacológicos en pacientes crónicos es un problema de salud pública, siendo especialmente evidente en pacientes con hipertensión, diabetes o dislipemia. Método: Estudio retrospectivo, observacional y longitudinal. 32 pacientes divididos en dos cohortes, con SPD y sin SPD, tratados con hipoglucemiantes, antihipertensivos o hipolipemiantes. Se hizo un análisis de los PRM/RNM, de los problemas de salud y de las intervenciones. Para cada paciente se realizaron análisis de colesterol, glucemia y presión arterial. Se calculó la correlación entre la tasa de incidencia de un PRM/RNM, y el resto de las variables, con cálculo de OR (IC 95%) y p-valor. Resultados: El 61,1% de los pacientes sin SPD son no adherentes y no retiran o retiran en exceso casi el 30% de la medicación. Los pacientes no adherentes tienen tres veces más posibilidades de padecer hipertensión y por encima de seis veces de presentar dislipemia (OR: 3,00 y 6,67). Los valores medios de presión arterial, glucemia y colesterol son más elevados en estos pacientes. Los PRM más frecuentes en este grupo de pacientes son los de interacción, probabilidad de efectos adversos y los problemas de salud no tratados. El número de RNM por tratamiento es más alto en los pacientes sin SPD (0,47 frente a 0,42). Más del 50% de las intervenciones proponen cambios en el tratamiento. Conclusiones: Los resultados avalan el uso de SPD en pacientes polimedicados y con las patologías estudiadas para reducir el riesgo de PRM/RNM y mejorar sus parámetros bioquímicos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Introduction: Non-adherence to pharmacological treatments in chronic patients is a public health problem, being especially evident in patients with hypertension, diabetes or dyslipidemia. Method: Retrospective, observational, longitudinal study. 32 patients were divided into two cohorts, with and without SPD, treated with hypoglycemic, antihypertensive or lipid-lowering drugs. An analysis of the DRP/NMR, health problems and interventions were performed. For each patient, cholesterol, glycemia and blood pressure analyses were performed. The correlation between the incidence rate of a DRP/NMR and the rest of the variables was calculated, with calculation of OR (95% CI) and p-value. Results: 61.1% of patients without SPD are non-adherent and do not pick up or pick up excessively almost 30% of the medication. Non-adherent patients are three times more likely to suffer from hypertension and more than six times more likely to present dyslipidemia (OR: 3.00 and 6.67). The mean values of blood pressure, blood glucose and cholesterol are higher in these patients. The most frequent DRPs in this group of patients are those interaction, probability of adverse effects and untreated health problems. The number of DRPs per treatment is higher in patients without SPD (0.47 vs. 0.42). More than 50% of the interventions propose changes in treatment. Conclusions: The results support the use of SPD in patients taking multiple medications and with the pathologies studied to reduce the risk of DRP/NMR and improve their biochemical parameters.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Atención farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[Adherencia terapéutica]]></kwd>
<kwd lng="es"><![CDATA[Farmacia comunitaria]]></kwd>
<kwd lng="es"><![CDATA[Polimedicado]]></kwd>
<kwd lng="en"><![CDATA[Pharmaceutical care]]></kwd>
<kwd lng="en"><![CDATA[Therapeutic adherence]]></kwd>
<kwd lng="en"><![CDATA[Community pharmacy]]></kwd>
<kwd lng="en"><![CDATA[Polymedicated]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DiMatteo]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Giordani]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lepper]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Croghan]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient adherence and medical treatment outcomes: a meta-analysis]]></article-title>
<source><![CDATA[Med Care]]></source>
<year>2002</year>
<volume>40</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>794-811</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rolnick]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pawloski]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Hedblom]]></surname>
<given-names><![CDATA[BD]]></given-names>
</name>
<name>
<surname><![CDATA[Asche]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Bruzek]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient characteristics associated with medication adherence]]></article-title>
<source><![CDATA[Clin Med Res]]></source>
<year>2013</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>54-65</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gossec]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Tubach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dougados]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ravaud]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review]]></article-title>
<source><![CDATA[Am J Med Sci]]></source>
<year>2007</year>
<volume>334</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>248-54</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Eurich]]></surname>
<given-names><![CDATA[DT]]></given-names>
</name>
<name>
<surname><![CDATA[Majumdar]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Padwal]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Tsuyuki]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Varney]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Meta-analysis of the association between adherence to drug therapy and mortality]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2006</year>
<volume>333</volume>
<numero>7557</numero>
<issue>7557</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avorn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review: good adherence (compared with poor adherence) to drug therapy is associated with a reduction in mortality]]></article-title>
<source><![CDATA[ACP J Club]]></source>
<year>2006</year>
<volume>145</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwint]]></surname>
<given-names><![CDATA[HF]]></given-names>
</name>
<name>
<surname><![CDATA[Stolk]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Faber]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gussekloo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bouvy]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence and knowledge of older patients with and without multidose drug dispensing]]></article-title>
<source><![CDATA[Age Ageing]]></source>
<year>2013</year>
<volume>42</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>620-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belfrage]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Koldestam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sjöberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wallerstedt]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of suboptimal drug treatment in patients with and without multidose drug dispensing--a cross-sectional study]]></article-title>
<source><![CDATA[Eur J Clin Pharmacol]]></source>
<year>2014</year>
<volume>70</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>867-72</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belfrage]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Koldestam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sjöberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wallerstedt]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients]]></article-title>
<source><![CDATA[Eur J Clin Pharmacol]]></source>
<year>2015</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>363-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio-Valera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Peñarrubia-María]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández-Vergel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Carvajal Tejadillo]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Sánchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aznar-Lou]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[March-Pujol]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Blanco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of pharmaceutical intervention in preventing relapses in depression in Primary Care]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2016</year>
<volume>48</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>308-15</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Gili]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Toro-Chico]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Encinas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Pedrero]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Portolés-Pérez]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical intervention on the therapeutic adherence in patients with chronic renal disease]]></article-title>
<source><![CDATA[Rev Calid Asist]]></source>
<year>2011</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>146-51</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Ulayar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gallardo López]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pons Llobet]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Murgadella Sancho]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Campins Bernadàs]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Merino Méndez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceutical intervention upon hospital discharge to strengthen understanding and adherence to pharmacological treatment]]></article-title>
<source><![CDATA[Farm Hosp]]></source>
<year>2012</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>118-23</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[MÁ]]></given-names>
</name>
<name>
<surname><![CDATA[García-Jiménez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Merino]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Martínez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Faus Dader]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of pharmacist involvement in adherence to medications in patients with high to moderate cardiovascular risk (Study EMDADER-CV-INCUMPLIMIENTO)]]></article-title>
<source><![CDATA[Aten Primaria]]></source>
<year>2011</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>245-53</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rabanaque]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gimeno-Miguel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Castel-Feced]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lallana]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar-Palacio]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patterns of statin adherence in primary cardiovascular disease prevention during the pandemic]]></article-title>
<source><![CDATA[Front Pharmacol]]></source>
<year>2022</year>
<volume>13</volume>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abughosh]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Vadhariya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Essien]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Esse]]></surname>
<given-names><![CDATA[TW]]></given-names>
</name>
<name>
<surname><![CDATA[Serna]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Gallardo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Boklage]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Holstad]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence]]></article-title>
<source><![CDATA[J Manag Care Spec Pharm]]></source>
<year>2019</year>
<volume>25</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1053-62</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alsaidan]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Alotaibi]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Thirunavukkarasu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[ALruwaili]]></surname>
<given-names><![CDATA[BF]]></given-names>
</name>
<name>
<surname><![CDATA[Alharbi]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Arnous]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Alsaidan]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Alduraywish]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
<name>
<surname><![CDATA[Alwushayh]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication Adherence and Its Associated Factors among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers of Eastern Province, Saudi Arabia]]></article-title>
<source><![CDATA[Medicina (Kaunas)]]></source>
<year>2023</year>
<volume>59</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baah-Nyarkoh]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alhassan]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Dwomoh]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Kretchy]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicated-related burden and adherence in patients with co-morbid type 2 diabetes mellitus and hypertension]]></article-title>
<source><![CDATA[Heliyon]]></source>
<year>2023</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eze]]></surname>
<given-names><![CDATA[UIH]]></given-names>
</name>
<name>
<surname><![CDATA[Akhumi]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Iheanacho]]></surname>
<given-names><![CDATA[CO]]></given-names>
</name>
<name>
<surname><![CDATA[Saka]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey]]></article-title>
<source><![CDATA[Explor Res Clin Soc Pharm]]></source>
<year>2022</year>
<volume>8</volume>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kristiansen]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Sverre]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Peersen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fagerland]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Gjertsen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gullestad]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Perk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dammen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Husebye]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vethe]]></surname>
<given-names><![CDATA[NT]]></given-names>
</name>
<name>
<surname><![CDATA[Munkhaugen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease]]></article-title>
<source><![CDATA[Atherosclerosis]]></source>
<year>2021</year>
<volume>336</volume>
<page-range>23-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez de Morentin de Benito]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Treceño Lobato]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valles Martín]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valoración de la incidencia de PRM/RNM en pacientes tratados con anticoagulantes orales y evaluación de la intervención en farmacia comunitaria]]></article-title>
<source><![CDATA[FarmaJournal]]></source>
<year>2023</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-47</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paulino]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
<name>
<surname><![CDATA[Bouvy]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Gastelurrutia]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Guerreiro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Buurma]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<collab>ESCP-SIR Rejkjavik Community Pharmacy Research Group</collab>
<article-title xml:lang=""><![CDATA[Drug related problems identified by European community pharmacists in patients discharged from hospital]]></article-title>
<source><![CDATA[Pharm World Sci]]></source>
<year>2004</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>353-60</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hämmerlein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Griese]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survey of drug-related problems identified by community pharmacies]]></article-title>
<source><![CDATA[Ann Pharmacother]]></source>
<year>2007</year>
<volume>41</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1825-32</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eickhoff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hämmerlein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Griese]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Schulz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2012</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>254-60</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
